ilyapharma.se valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Ilya Pharma |
| Description | Happenings Ilya Pharma AB - Developing the next-generation biological drugs for treating wounds in skin and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 91.189.44.215 |
| Location | Sweden |
Related Websites
| Site | Rank |
More to Explore
ilyapharma.se Valuation
|
US$271,247
Last updated: 2023-05-11 10:54:02
ilyapharma.se has Semrush global rank of 39,020,911. ilyapharma.se has an estimated worth of US$ 271,247, based on its estimated Ads revenue. ilyapharma.se receives approximately 31,298 unique visitors each day. Its web server is located in Sweden, with IP address 91.189.44.215. According to SiteAdvisor, ilyapharma.se is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$271,247 |
| Daily Ads Revenue | US$251 |
| Monthly Ads Revenue | US$7,512 |
| Yearly Ads Revenue | US$90,138 |
| Daily Unique Visitors | 2,087 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ilyapharma.se. | A | 297 | IP: 91.189.44.215 |
| ilyapharma.se. | NS | 1800 | NS Record: ns1.ballou.se. |
| ilyapharma.se. | NS | 1800 | NS Record: ns3.ballou.se. |
| ilyapharma.se. | NS | 1800 | NS Record: ns2.ballou.se. |
| ilyapharma.se. | MX | 300 | MX Record: 0 ilyapharma-se.mail.protection.outlook.com. |
| ilyapharma.se. | TXT | 300 | TXT Record: MS=ms56486044 |
| ilyapharma.se. | TXT | 3600 | TXT Record: v=spf1 a include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-11 10:54:02
| Home Happenings About Drug development Clinical trials Collaborations and partners Investors Board and Management Contact Delivering local-acting immunotherapies to patients Next Happenings 2023-05-04 Presentation of results from the SITU-SAFE study at EWMA 2023 in Milan on Friday May 5th Read more --> 2023-05-04 The value of regulatory interactions developing a new modality in gene therapy- presentation at ISCT Paris May 31 - June 3 Read more --> 2023-03-03 Ilya Pharma have had a successful preIND meeting with the FDA related to the development of ILP100-Oral Read more --> More news In press 2023-04-15 CEO Evelina Vågesjö featured in - 10 most innovative women leaders in Life Science 2023 2022-09-22 Ilya Pharma reports enrolment of first patient in phase 2a trial More In press Twitter Tweets by ilyapharma Next About Ilya Pharma, a clinical stage biopharmaceutical development company is currently pursuing three clinical programs with fully owned assets from its proprietary |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 148 Content-Type: text/html; charset=UTF-8 Location: http://www.ilyapharma.se/ Server: Microsoft-IIS/10.0 X-Frame-Options: sameorigin Date: Thu, 04 Nov 2021 14:49:12 GMT HTTP/1.1 301 Moved Permanently Content-Length: 149 Content-Type: text/html; charset=UTF-8 Location: https://www.ilyapharma.se/ Server: Microsoft-IIS/10.0 X-Frame-Options: sameorigin Date: Thu, 04 Nov 2021 14:49:12 GMT HTTP/2 200 cache-control: private content-length: 27865 content-type: text/html; charset=utf-8 x-frame-options: sameorigin date: Thu, 04 Nov 2021 14:49:13 GMT |
ilyapharma.se Whois Information
# state: active domain: ilyapharma.se holder: loj3472-1836849 admin-c: - tech-c: - billing-c: - created: 2016-04-12 modified: 2021-06-14 expires: 2022-04-12 nserver: ns1.ballou.se nserver: ns2.ballou.se nserver: ns3.ballou.se dnssec: unsigned delegation registry-lock: unlocked status: ok registrar: Loopia AB |